SSA
HGEN

Schonfeld Strategic Advisors’s HUMANIGEN, INC. HGEN Stock Holding History

Schonfeld Strategic Advisors’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-85,100
Closed -$151K – 3290
2022
Q2 		$151K Sell
85,100
-12,300
-13% -$27.6K ﹤0.01% 2004
2022
Q1 		$293K Buy
+97,400
New +$261K ﹤0.01% 1704
2021
Q3 		– Sell
-11,900
Closed -$207K – 2579
2021
Q2 		$207K Buy
+11,900
New +$217K ﹤0.01% 1650

Other funds holding HGEN

GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Schonfeld Strategic Advisors's HGEN Position: Q3 2022 in Review

Schonfeld Strategic Advisors sold out of HUMANIGEN, INC. (HGEN) in Q3 2022, closing a stake of 85,100 shares — an estimated $151K sold.

Schonfeld Strategic Advisors first reported a position in HGEN in Q2 2021 and held it in 3 quarters. The position peaked at $293K in Q1 2022. 53 funds tracked by Wall St. Rank hold HGEN as of Q3 2022.

  • Schonfeld Strategic Advisors reported no remaining HUMANIGEN, INC. position as of Q3 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 85,100 HUMANIGEN, INC. shares in Q3 2022, an estimated $151K.
  • Schonfeld Strategic Advisors first reported a position in HUMANIGEN, INC. in Q2 2021 and held it in 3 quarters.
  • Schonfeld Strategic Advisors's HUMANIGEN, INC. position peaked at $293K in Q1 2022.
  • 53 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.